摘要:
An ink jet printing head includes: a plurality of piezoelectric actuators arranged in rows on a substrate, each row including first piezoelectric elements and second piezoelectric elements which are alternately arrayed along the row, the first piezoelectric elements being actuatable to apply a compressive force to ink in accordance with print signals, the second piezoelectric elements being fixed and not actuated; and an ink chamber unit which includes ink chambers located above the first piezoelectric elements and containing ink. The ink chamber unit includes: an oscillation plate including diaphragm portions which are connected to the first piezoelectric elements and independently deformable in a direction perpendicular to the substrate by the first piezoelectric elements when actuated; and a nozzle plate which includes nozzles being located above the diaphragm portions and opened to the ink chambers, so that ink drops are respectively forced out from the nozzles when the first piezoelectric elements are actuated.
摘要:
A process for producing a polyorganosiloxane-based thermoplastic resin which comprises graft polymerizing (3) at least one vinyl monomer using (4) an initiator which is an organic peroxide which, upon decomposition, produces an organic radical represented by the structural formula: ##STR1## wherein R.sup.2, R.sup.3 and R.sup.4 represent independently hydrogen atoms or alkyl groups having 1 to 10 carbon atoms, in the presence of (2) a polyorganosiloxane.
摘要:
A manufacturing method for semiconductor device includes: loading a wafer to a reaction chamber and placing the wafer on a support member; supplying process gas including source gas to a surface of the wafer, controlling a heater output and heating the wafer to a predetermined temperature while rotating the wafer at a first rotational speed, and thereby forming a film on a surface of the wafer; stopping supplying the source gas; decreasing a rotational speed of the wafer to a second rotational speed which enables an offset balance of the wafer to be maintained and stopping the heater output; and decreasing a temperature of the wafer while rotating the wafer at the second rotational speed.
摘要:
The present invention provides a compound represented by Formula (I): [wherein R1 represents CONR1aR1b (wherein R1a and R1b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R1a and R1b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, R2 represents a hydrogen atom, CONR2aR2b (wherein R2a and R2b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R2a and R2b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group), NR2cR2d (wherein R2c and R2d may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkanoyl, substituted or unsubstituted aroyl, substituted or unsubstituted heteroaroyl, substituted or unsubstituted ararkyl, substituted or unsubstituted lower alkylsulfonyl or substituted or unsubstituted lower arylsulfonyl) or the like].
摘要:
To provide a liquid crystal aligning agent which can provide a liquid crystal display element having a liquid crystal alignment film provided with alignability for liquid crystal molecules by rubbing without fail and having excellent liquid crystal alignability. The liquid crystal aligning agent comprises at least one selected from a polyamic acid having a specific structure having 2 or 3 rings, and an imidized polymer of the polyamic acid and further having alkyl group having the main chain with 8 or more carbon atoms, perfluoroalkyl group having the main chain with 3 or more carbon atoms, or 1,1-cycloalkylene group having 6 or more carbon atoms which may be substituted.
摘要:
(wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R6 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents —C(═W)R6 or the like; R3 represents a hydrogen atom, —C(═WA)R6A, or the like)Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.
摘要翻译:(其中R 1和R 4相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的低级炔基,取代或未取代的低级烯基等; R 6表示取代或未取代的杂环基,取代或未取代的 未取代的芳基等; R 2表示-C(= W)R 6等; R 3表示氢原子,-C(= W)R 6 A等)。 提供包含由上述通式(I)表示的噻二唑啉衍生物或其药理学上可接受的盐作为活性成分的抗肿瘤剂。
摘要:
(wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents —C(═W)R6 or the like; R3 represents a hydrogen atom, —C(═WA)R6A, or the like) Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.
摘要翻译:(其中R 1和R 4相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的低级炔基,取代或未取代的低级烯基等; R 5表示取代或未取代的杂环基,取代或未取代的 未取代的芳基等; R 2表示-C(= W)R 6等; R 3表示氢原子,-C(= W)R 6 A等)。抗肿瘤剂包含上述一般所述的噻二唑啉衍生物 提供式(I)或其药理学上可接受的盐作为活性成分。
摘要:
(wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents —C(═W)R6 or the like; R3 represents a hydrogen atom, —C(═WA)R6A, or the like) Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.
摘要翻译:(其中R 1和R 4相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的低级炔基,取代或未取代的低级链烯基 等等; R 5表示取代或未取代的杂环基,取代或未取代的芳基等; R 2表示-C(-W)R SUP > 6个等等; R 3表示氢原子,-C(-W A)SO 6,或者 提供包含由上述通式(I)表示的噻二唑啉衍生物或其药理学上可接受的盐作为有效成分的抗肿瘤剂。
摘要:
A water absorbing agent comprising a crosslinked polymer including a water-soluble vinyl monomer (a1) and/or a vinyl monomer (a2) that is formed into the water-soluble vinyl monomer (a1) by hydrolysis, and a crosslinking agent (b) as an essential constituting unit, wherein the following formulae (1) and (2) are satisfied; a process for its production, and absorbers and absorbent articles made by the water absorbing agent. (Y)≧−1.14(X)+69.5 (1) (X)=((x1)2+4×(x2)2)1/2 (2) wherein (x1) denotes a water-retention amount (g/g) of the water absorbing agent after being soaked in a physiological saline for one hour; (x2) denotes an absorption amount (g/g) of the water absorbing agent after being soaked in a physiological saline under loading of 0.9 psi for one hour; and (Y) denotes a liquid permeation speed (ml/min) of a physiological saline after the water absorbing agent is soaked in a physiological saline under loading of 0.3 psi for one hour. The water-absorbing agent enables easy production of absorbent articles exhibiting high absorption performance in any state, and is suitable for use in disposable diapers, sanitary napkins, and other sanitary goods.
摘要:
(wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents —C(═W)R6 or the like; R3 represents a hydrogen atom, —C(═WA)R6A, or the like) Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.
摘要翻译:(其中R 1和R 4相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的低级炔基,取代或未取代的低级链烯基 等等; R 5表示取代或未取代的杂环基,取代或未取代的芳基等; R 2表示-C(-W)R SUP > 6个等等; R 3表示氢原子,-C(-W A)SO 6,或者 提供包含由上述通式(I)表示的噻二唑啉衍生物或其药理学上可接受的盐作为有效成分的抗肿瘤剂。